Cyrano Therapeutics, Inc.

This will be the first major therapy to treat patients who have lost their sense of smell and flavor.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Washington, DC, US
  • Currency USD
  • Employees 3
  • Incorporation Type C-corp
  • Website CyranoTherapeutics.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free